688276 Stock Overview
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Changchun BCHT Biotechnology Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥26.37 |
| 52 Week High | CN¥60.93 |
| 52 Week Low | CN¥21.18 |
| Beta | 0.018 |
| 11 Month Change | -0.79% |
| 3 Month Change | 8.30% |
| 1 Year Change | -55.70% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -57.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688276 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 2.4% | -2.5% | -2.6% |
| 1Y | -55.7% | -20.0% | 4.2% |
Return vs Industry: 688276 underperformed the CN Biotechs industry which returned -20% over the past year.
Return vs Market: 688276 underperformed the CN Market which returned 4.2% over the past year.
Price Volatility
| 688276 volatility | |
|---|---|
| 688276 Average Weekly Movement | 9.6% |
| Biotechs Industry Average Movement | 8.9% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688276 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688276's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,289 | Wei Kong | www.bchtpharm.com |
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd.
Changchun BCHT Biotechnology Co. Fundamentals Summary
| 688276 fundamental statistics | |
|---|---|
| Market cap | CN¥10.91b |
| Earnings (TTM) | CN¥414.29m |
| Revenue (TTM) | CN¥1.61b |
26.3x
P/E Ratio6.8x
P/S RatioIs 688276 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688276 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.61b |
| Cost of Revenue | CN¥220.26m |
| Gross Profit | CN¥1.39b |
| Other Expenses | CN¥972.96m |
| Earnings | CN¥414.29m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.00 |
| Gross Margin | 86.30% |
| Net Profit Margin | 25.77% |
| Debt/Equity Ratio | 1.5% |
How did 688276 perform over the long term?
See historical performance and comparison